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Abstract. 
 
Phosphatidylinositide (PI) 3-kinase binds to 
tyrosyl-phosphorylated insulin receptor substrate-1 
(IRS-1) in insulin-treated adipocytes, and this step 
plays a central role in the regulated movement of the 
glucose transporter, GLUT4, from intracellular vesicles 
to the cell surface. PDGF, which also activates PI 3-kinase 
in adipocytes, has no significant effect on GLUT4 traf-
ficking in these cells. We propose that this specificity may 
be mediated by differential localization of PI 3-kinase 
in response to insulin versus PDGF activation. Using 
subcellular fractionation in 3T3-L1 adipocytes, we show 
that insulin- and PDGF-stimulated PI 3-kinase activi-
ties are located in an intracellular high speed pellet 
(HSP) and in the plasma membrane (PM), respectively. 
The HSP is also enriched in IRS-1, insulin-stimulated 
tyrosyl-phosphorylated IRS-1 and intracellular 
GLUT4-containing vesicles. Using sucrose density gra-
dient sedimentation, we have been able to segregate 
the HSP into two separate subfractions: one enriched in 
IRS-1, tyrosyl-phosphorylated IRS-1, PI 3-kinase as 
well as cytoskeletal elements, and another enriched in 
membranes, including intracellular GLUT4 vesicles. 
Treatment of the HSP with nonionic detergent, liber-
ates all membrane constituents, whereas IRS-1 and PI 
3-kinase remain insoluble. Conversely, at high ionic 
strength, membranes remain intact, whereas IRS-1 and 
PI 3-kinase become freely soluble. We further show 
that this IRS-1–PI 3-kinase complex exists in CHO cells 
overexpressing IRS-1 and, in these cells, the cytosolic 
pool of IRS-1 and PI 3-kinase is released subsequent to 
permeabilization with Streptolysin-
 
O
 
, whereas the par-
ticulate fraction of these proteins is retained. These 
data suggest that IRS-1, PI 3-kinase, as well as other 
signaling intermediates, may form preassembled com-
plexes that may be associated with the actin cytoskele-
ton. This complex must be in close apposition to the 
cell surface, enabling access to the insulin receptor and 
presumably other signaling molecules that somehow 
confer the absolute specificity of insulin signaling in 
these cells.
C
 
ell
 
 proliferation, differentiation, and metabolism
are regulated by an extensive array of hormones,
cytokines, and growth factors. Although the bio-
logical endpoints of these regulatory mechanisms are quite
unique, there is tremendous overlap during the intermedi-
ate steps comprising the signal transduction machinery.
For example, insulin, EGF, PDGF, haematopoietic factors
including B cell receptor antigen and several interleukins,
and clotting factors, such as thrombin, all stimulate the
Ras/mitogen–activated protein kinase (MAPK)
 
1
 
 and the
phosphatidylinositide (PI) 3-kinase–Akt pathways (Kuc-
era and Rittenhouse, 1990; Cambier and Campbell, 1992;
Gold et al., 1992; Lev et al., 1992; Izuhara and Harada,
1993; Kazlauskas, 1994). Yet each of these factors initiates
a specific biological response in accord with the physiolog-
ical requirements of the cell. Thus, a major challenge is to
establish how different hormones and growth factors
achieve their biological specificity, in view of this apparent
redundancy in signaling. One way of achieving specificity
in multicellular organisms is via the cell-specific expres-
sion of different receptors. Another, is by a combinatorial
mechanism of signaling. This latter mechanism, which is
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1. 
 
Abbreviations used in this paper
 
: anti-pY, anti-phosphotyrosine; 
 
b
 
-OG,
 
b
 
-octylglucoside; CYT, cytosol; HDM, high density microsomes; HSP,
high speed pellet; IC, intracellular; IR, insulin receptor; IRS-1, insulin re-
ceptor substrate-1; MAPK, mitogen-activated protein kinase; M/N, mito-
chondria/nuclei; PI, phosphatidylinositide; PIP, phosphatidylinositol 3
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-
phosphate; PM, plasma membrane; SLO, Streptolysin-
 
O
 
; T
 
x
 
-100, Triton
X-100.
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still probably the most commonly held view, has been sup-
ported by the realization that each of the signaling mole-
cules that make up these signaling pathways belong to
large gene families (Marshall, 1994; Toker and Cantley,
1997). In unicellular organisms, such as yeast, there are at
least three isoforms of both MAPK and MAPK-kinase,
and each isoform is located on distinct downstream path-
ways that coordinate a particular biological action in re-
sponse to unique stimuli (Posas and Saito, 1997).
Another level of specificity may be derived from the in-
tracellular location of different signaling molecules. For
example, several growth factors stimulate the transloca-
tion of MAPK from the cytosol to the nucleus, where it is
presumably capable of directly accessing downstream tar-
gets involved in transcriptional regulation (Gonzalez et al.,
1993). Other signaling molecules, such as Raf and PI 3-kinase,
also move from the cytosol to membrane compartments in
response to activation (Susa et al., 1992; Traverse et al.,
1993). Presumably the intracellular targeting of these pro-
teins facilitates their interaction with the appropriate
downstream substrates and/or signaling molecules. In-
deed, the expression of Raf and PI 3-kinase isoforms, con-
taining membrane-targeting motifs, results in the constitu-
tive activation of these proteins and downstream signaling
cascades (Stakoe et al., 1994; Klippel et al., 1996). In the
case of PI 3-kinase, indiscriminate membrane targeting re-
sults in the activation of multiple signaling pathways, thus
underscoring the absolute need to preserve the correct
compartmentalization of this molecule (Klippel et al., 1996).
This raises the possibility that the recruitment of signaling
molecules to their precise site of action within the cell may
be a central feature of biological specificity. PI 3-kinase
represents one example where pleiotropism may be
achieved by regulating its site of action, because it has
been reported that this enzyme can be recruited to a vari-
ety of intracellular locations, such as the plasma mem-
brane (PM; Susa et al., 1992), the microtubule organiza-
tion centre (Kapeller et al., 1993), intracellular vesicles
(Heller-Harrison et al., 1996), or cytoskeleton (Zhang et al.,
1992), in response to different growth factors.
The present studies focus on the regulation of glucose
metabolism by insulin. Insulin triggers a number of intra-
cellular metabolic pathways in muscle and adipose tissue,
resulting in increased glycogen and/or lipid storage. The
rate of glucose entry into these cells is an important rate
determining step for each of these processes, and so this
has become the focal point of numerous studies. Insulin
stimulates glucose transport in adipocytes by as much as
30-fold, in a process that involves the regulated exocytic
movement of a facilitative glucose transporter (GLUT4)
from intracellular membranes to the cell surface (James et
al., 1989; Slot, 1991). This is an ideal biological step with
which to dissect the specificity of downstream signaling
pathways because it is uniquely regulated by insulin and
other hormones, such as EGF, PDGF, or thrombin are in-
capable of initiating this response (Robinson et al., 1993;
Vandenberghe et al., 1994; Wiese et al., 1995).
One signaling protein that has been implicated in insu-
lin-regulated glucose transport is PI 3-kinase (Kotani et al.,
1995). PI 3-kinase is a member of a lipid kinase family and
consists of two subunits: a p85 regulatory and a p110 cata-
lytic subunit (Hiles et al., 1992). The p85 subunit contains
two SH2 domains and an SH3 domain that facilitate the
interaction of this enzyme with other proteins. Insulin in-
duces a rapid and marked accumulation of the reaction
products of PI 3-kinase activity, phosphatidylinositol 3,4
bisphosphate, and phosphatidylinositol 3,4,5 trisphos-
phate, in insulin-sensitive cells (Kelly et al., 1992). The
time course of insulin-activated PI 3-kinase parallels that
of insulin-stimulated glucose transport (Kelly et al., 1992).
In addition, potent PI 3-kinase inhibitors, such as the fun-
gal metabolite, wortmannin, and the synthetic compound,
LY294002, inhibit both insulin-stimulated glucose trans-
port and the translocation of GLUT4 to the cell surface
(Okada et al., 1994). Consistent with these studies, domi-
nant negative mutants of the p85 regulatory subunit block
insulin-triggered GLUT4 translocation in adipocytes (Ko-
tani et al., 1995), whereas constitutively activated PI 3-kinase
isoforms promote GLUT4 translocation in these cells (Kat-
agiri et al., 1996). Collectively, these studies provide com-
pelling evidence in favor of a role for PI 3-kinase in the
regulation of glucose transport by insulin.
One of the challenges in defining a specific role for PI
3-kinase in the regulation of glucose transport is that other
growth factors, such as PDGF, also stimulate PI 3-kinase
activity in adipocytes, but have no significant effect on glu-
cose transport in these cells (Wiese et al., 1995). The mode
of PI 3-kinase activation is quite different for these two
hormones, however, in that PI 3-kinase binds directly to
the PDGF receptor in response to PDGF (Kazlauskas et al.,
1992), whereas, in response to insulin, PI 3-kinase associ-
ates with one of the major substrates of the insulin recep-
tor, insulin receptor substrate-1 (IRS-1; Sun et al., 1991).
IRS-1 is a 160-kD protein that is phosphorylated on multi-
ple tyrosine residues in response to insulin. Two of these
phosphorylation sites exist within a consensus motif
(YMXM) for the binding of the p85 subunit of PI 3-kinase
(Sun et al., 1992). IRS-1 also contains a phosphotyrosyl-
binding domain that appears to facilitate interaction with
the insulin receptor (Gustafson et al., 1995). In addition,
IRS-1 contains a pleckstrin homology domain that is also
required for insulin-dependent phosphorylation (Yenush
et al., 1996). IRS-1 is rapidly phosphorylated in intact cells
after insulin stimulation (maximal within 20–40 s), and it is
believed that a significant proportion of IRS-1 (
 
z
 
50%)
undergoes phosphorylation in response to a maximal insu-
lin challenge (Madoff et al., 1988). It has been suggested
that phosphorylation of IRS-1 occurs at the cell surface
because efficient phosphorylation of this protein can be
achieved under conditions where internalization of the in-
sulin receptor is inhibited (Heller-Harrison et al., 1995).
Despite this claim, the intracellular location of IRS-1 is not
known. IRS-1 does not contain a transmembrane domain,
nor is there any evidence for posttranslational modifica-
tion of the protein that would enable it to associate with
membranes. In CHO cells that have been transfected with
the IRS-1 cDNA, the protein appears largely cytosolic as
determined by immunofluorescence microscopy (Sun et al.,
1992). Subcellular fractionation studies in adipocytes,
however, suggest that IRS-1 is predominantly membrane
associated (Kelly and Ruderman, 1993). Establishing the
intracellular distribution of IRS-1 and PI 3-kinase in adi-
pocytes may provide clues concerning the basis for the bi-
ological specificity of insulin action in these cells.
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In the present study, we have used differential centrifu-
gation and sucrose density gradient sedimentation to study
the distribution of signaling proteins in adipocytes. We
show that insulin and PDGF recruit PI 3-kinase to distinct
intracellular locations: with PDGF, the major increase was
observed in the PM, whereas with insulin, PI 3-kinase was
recruited to a high speed pellet fraction (HSP) that also
contained IRS-1 and the intracellular pool of GLUT4. Us-
ing flotation and velocity sedimentation analysis, we were
able to further fractionate the HSP fraction into two dis-
crete components, one comprising intracellular mem-
branes enriched in GLUT4 and the 
 
g
 
-adaptin subunit of
the Golgi clathrin-coat, and another containing large pro-
tein complexes and cytoskeletal elements. IRS-1 and PI
3-kinase were enriched in the latter fraction, which was de-
tergent insoluble, but readily dissociated at high ionic
strength. Based on these observations, we propose that
signaling molecules such as IRS-1 and PI 3-kinase may be
specifically targeted to a proteinaceous matrix in adipo-
cytes that may be held in place via interactions with the cy-
toskeleton. Based on the specificity with which insulin acts
upon these effectors at this location, we suggest that this
matrix must be readily accessible to the PM, and uniquely
affords activation of appropriate downstream targets, such
as GLUT4 translocation.
 
Materials and Methods
 
Reagents
 
3T3-L1 murine fibroblasts were obtained from the American Type Cul-
ture Collection (Rockville, MD). All tissue culture reagents were ob-
tained from GIBCO BRL (Gaithersburg, MD), except for FCS, which was
purchased from Trace Biosciences (Clayton, Australia). Insulin was pur-
chased from Calbiochem Corp. (San Diego, CA) and PDGF.B was pur-
chased from Boehringer Mannheim (Mannheim, Germany) and Upstate
Biotechnology Inc. (Lake Placid, NY). Acrylamide/bis-acrylamide (29:1)
was obtained from Bio-Rad (Hercules, CA), and BSA was purchased
from ICN Pharmaceuticals Inc. (Costa Mesa, CA). Unless specified, all
other biochemicals were obtained from the Sigma Chemical Co. (St.
Louis, MO). Streptolysin-
 
O
 
 (SLO) was obtained from S. Bhakdi (Univer-
sity of Mainz, Mainz, Germany). BCA reagent, used in protein assays, was
obtained from Pierce (Rockville, IL).
 
Antibodies
 
The antibodies used in this study were obtained from the following
sources: anti-phosphotyrosine antibody (4G10) from B. Druker (Oregon
Health Sciences University, Portland, OR); anti–IRS-1 polyclonal anti-
body from G. Lienhard (Dartmouth University, Dartmouth, UK); anti-
Grb2 polyclonal antibodies from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA); anti-mSos polyclonal antibodies from D. Bowtel (Peter Mac-
Callum Cancer Institute, Melbourne, Australia); anti–
 
g
 
-adaptin poly-
clonal antibodies from M. Robinson (Cambridge University, Cambridge,
UK); anti-Shc and anti-p85
 
PAN
 
 polyclonal antibodies were from Upstate
Biotechnology Inc. The GLUT4 antibody (R820) has been described in
detail previously (James et al., 1989).
 
Cell Culture
 
3T3-L1 fibroblasts were cultured in DME supplemented with 10% new-
born calf serum, L-glutamine (2 mM), penicillin (50 U/ml), and streptomy-
cin sulfate (50 mg/ml). Cells were grown to confluence and differentiated
to form adipocytes, as previously described (Piper et al., 1991). Adipo-
cytes were routinely used at 10–20 d postdifferentiation. Before experi-
ments, 3T3-L1 adipocytes were incubated in Krebs-Ringer phosphate so-
lution (2.5 mM Hepes, pH 7.4, 120 mM NaCl, 6 mM KCl, 1.2 mM MgSO
 
4
 
,
10 mM CaCl
 
2
 
, 0.4 mM NaH
 
2
 
PO
 
4
 
, 0.6 mM Na
 
2
 
HPO
 
4
 
), supplemented with
2% BSA for 2 h at 37
 
8
 
C to establish basal conditions.
CHO cells, overexpressing the insulin-receptor (IR) and IRS-1 (CHO/
IR/IRS-1; Sun et al., 1992), were a generous gift from M. White (Harvard
University, Cambridge, MA). CHO/IR/IRS-1 cells were routinely cultured
in DME containing 10% FCS, L-glutamine (2 mM), penicillin (50 U/ml), and
streptomycin sulfate (50 mg/ml) supplemented with geneticin (0.8 mg/ml).
Before experiments, confluent CHO/IR/IRS-1 cells were brought to basal
conditions by incubation in DME, free of additives, for 2 h at 37
 
8
 
C.
 
Cell Permeabilization
 
In some experiments, cells cultured in 100 mm culture dishes were perme-
abilized by treatment of cells with the bacterial endotoxin, SLO. Prelimi-
nary experiments established that the concentration of SLO required to
facilitate propidium iodide staining of the nucleus in 100% of CHO cells
and adipocytes was 0.5 
 
m
 
g/ml and 2.0 
 
m
 
g/ml, respectively. Before perme-
abilization, cells were brought to basal conditions, as outlined above, and
washed once in prechilled intracellular (IC) buffer (20 mM Hepes, pH 7.2,
140 mM potassium glutamate, 5 mM EGTA, 5 mM MgCl, 5 mM NaCl).
To facilitate the binding of SLO to the cell surface, cells were incubated
with the appropriate concentration of SLO in 2 ml of IC buffer for 5 min
at 4
 
8
 
C, and then washed once with cold IC buffer. Permeabilization of
cells was initiated by incubating cells in 2 ml of IC buffer containing 1 mg/ml
BSA, 1 mM dithiothreitol, and an ATP regeneration system (40 IU creat-
ine phosphokinase, 5 mM creatine phosphate, 1 mM ATP) at 37
 
8
 
C for 15
min. Cells were subsequently washed, and subcellular fractions obtained
as outlined below.
 
Subcellular Fractionation of 3T3-L1 Adipocytes
 
Whole cell lysates were prepared from 3T3-L1 adipocytes cultured in 35
mm tissue culture dishes. After growth factor treatment, cells were rinsed
twice in ice cold PBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH
 
2
 
PO
 
4
 
, 1.5
mM KH
 
2
 
PO
 
4
 
, 8 mM Na
 
2
 
HPO
 
4
 
, pH 7.4). Washed cells were frozen in liq-
uid N
 
2
 
, and stored at 
 
2
 
70
 
8
 
C. Immediately before assay, frozen cell mono-
layers were scraped into 500 
 
m
 
l of ice cold lysis buffer A (20 mM Tris, pH
7.5, 1 mM EDTA, 137 mM NaCl, 10% glycerol, 1% NP-40, 1 mM PMSF)
containing phosphatase inhibitors (2 mM sodium orthovanadate, 10 mM
sodium fluoride, 1 mM 
 
tetra
 
-sodium pyrophosphate, and 1 mM ammo-
nium molybdate), and mixed for 15 min at 4
 
8
 
C. Cell lysates were centri-
fuged at 12,500 
 
g
 
 in a microfuge (Beckman Instruments, Inc., Palo Alto,
CA) for 15 min at 4
 
8
 
C, and the resultant supernatant cleared of fat parti-
cles by filtration through a 0.45-
 
m
 
m filtration unit (Millipore Corp., Bed-
ford, MA).
Subcellular fractions were prepared from 3T3-L1 adipocytes, cultured
in 100 mm tissue culture plates, as previously described (Piper et al.,
1991), with minor modifications. After growth factor treatment, cells were
rinsed rapidly in ice cold TES (20 mM Tris, pH 7.4, 5 mM EDTA, 250 mM
sucrose), and then harvested in ice cold TES containing protease inhibi-
tors (10 
 
m
 
g/ml aprotinin, 10 
 
m
 
g/ml leupeptin, 250 
 
m
 
M PMSF), and phos-
phatase inhibitors, as noted above. The suspension was homogenized by
10 passages through a cylinder cell homogenizer (H and Y Enterprise,
Redwood City, CA) and subcellular fractions prepared by sequential dif-
ferential centrifugation steps. Briefly, the homogenate was subjected to
centrifugation at 13,000 
 
g
 
 using an SS-34 rotor (Sorvall Instruments Divi-
sion, Newton, CT) at 4
 
8
 
C for 20 min. The resultant pellet was washed and
resuspended in 1 ml of TES, layered onto a 1.12 M sucrose cushion and
centrifuged at 77,000 
 
g
 
 for 1 h using an SW-41 rotor (Beckman Instru-
ments Inc.) to obtain PM. The 13,000 
 
g
 
 supernatant was centrifuged at
30,000 
 
g
 
 using an SS-34 Rotor (Sorvall Instruments Division) for 30 min to
obtain a pellet designated high density microsomes (HDM). The superna-
tant was cleared of remaining fat particles by filtering through a 0.45-
 
m
 
m
filter (Millipore Corp.) and centrifuged at 175,000 
 
g
 
 using a Ti-80 rotor
(Beckman Instruments Inc.) to obtain a supernatant, designated cytosol
(CYT) and high speed pellet (HSP). In previous studies, this pellet has
been referred to as the low density microsomal fraction (Piper et al.,
1991). However, the studies described herein suggest that a large propor-
tion of the protein in this fraction is not directly associated with microso-
mal membranes, in which case, HSP is a more appropriate designation.
In some experiments the effects of growth factors on the subcellular
distribution of GLUT4 was assessed using the PM lawn technique (Robin-
son et al., 1992). Briefly, adipocytes cultured on coverslips were treated
with or without growth factor, and then sonicated to remove the majority
of cell components except for fragments of plasma membrane that re-
mained attached to the coverslip. Coverslips were then incubated in
GLUT4 specific antisera, followed by a second incubation with FITC-con-
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jugated secondary antibody. Immunolabeling was visualized by fluores-
cence microscopy using an Axioscope fluorescent microscope (Zeiss,
Oberkochen, Germany).
 
Subcellular Fractionation of CHO Cells
 
An abbreviated differential centrifugation procedure was used to obtain
subcellular fractions from CHO/IR/IRS-1 cells. Untreated or insulin-
treated cells were washed twice in prechilled fractionation buffer (HES:
20 mM Hepes, pH 7.4, 1 mM EDTA, 250 mM sucrose), and homogenized
in HES, supplemented with protease and phosphatase inhibitors, by 15
passages with a teflon homogenizer. The homogenate was then subjected
to centrifugation at 15,000 
 
g
 
 at 4
 
8
 
C for 15 min using an SS-34 rotor (Sor-
vall Instruments Division). The 15,000 
 
g
 
 supernatant was centrifuged at
175,000 
 
g
 
 at 4
 
8
 
C for 1 h 15 min using a Ti-80 rotor (Beckman Instruments
Inc.) to yield a pellet designated HSP, and a supernatant designated CYT.
Fractions were subjected to immunoblotting or velocity sedimentation
analysis as described below.
 
Immunoprecipitation and PI 3-Kinase Assay
 
Whole cell lysates (500 
 
m
 
g), subcellular membrane fractions (25–100 
 
m
 
g of
protein), and CYT (200 
 
m
 
g of protein) prepared from treated cells, were
diluted in lysis buffer to a final volume of 500 
 
m
 
l and subjected to immuno-
precipitation by incubation with an anti-phosphotyrosine antibody (4G10)
prelinked to protein A/G beads (Pierce). Immunoprecipitations were per-
formed for 2–4 h, or overnight at 4
 
8
 
C. Immunoprecipitated complexes
were collected by centrifugation at 13,000 
 
g
 
 for 10 s and washed sequen-
tially in 1% NP-40 in PBS, pH 7.4, and 50 mM LiCl in 100 mM Tris, pH
7.5, and then washed twice in 100 mM NaCl in 10 mM Tris, pH 7.5. In
some experiments, an aliquot of immunocomplexes was removed during
the last wash and retained for Western blotting analysis. The remaining
immunocomplexes were assayed for PI 3-kinase activity as previously out-
lined (Hara et al., 1994), using phosphatidylinositol as substrate. The reac-
tion products were spotted onto silica-60–coated plates (Merck, Darm-
stadt, Germany) and subjected to TLC. The radio-labeled phospholipid
product was visualized by autoradiography and then excised from silica
plates and quantitated by scintillation counting (Packard 1900CA; Pack-
ard Instrument Co. Inc., Downers Grove, IL). Radio-labeled phosphati-
dylinositol 3-phosphate (PIP) was identified on the basis of its disappear-
ance in wortmannin-treated cells (data not shown).
 
Immunoblotting
 
Proteins were subjected to SDS-PAGE and transferred to Immobilon-P
PVDF membranes (Millipore Corp.). Membranes were incubated with ei-
ther 5% skim milk powder or 3% BSA in TBST (20 mM Tris, pH 7.6,
150 mM NaCl, 0.05% Tween-20), and subsequently incubated with pri-
mary antibody, washed and incubated with the appropriate horseradish-
peroxidase-linked secondary antibodies (Amersham Intl., Little Chalfont,
UK) for 1 h at room temperature. To visualize immunoreactive proteins,
membranes were incubated with enhanced chemiluminescence substrate,
(Amersham Intl.) or Supersignal (Pierce), and subjected to autoradiogra-
phy by exposing each membrane to film (X-OMAT; Fuji, Tokyo, Japan).
 
Treatment of 3T3-L1 Adipocyte HSP Fractions with 
Detergent or Ionic Buffer
 
The HSP fraction was prepared from nontreated and insulin-treated 3T3-L1
adipocytes, in fractionation buffer (20 mM Hepes, pH 7.4, 1 mM EDTA,
250 mM sucrose; HES), containing protease and phosphatase inhibitors as
detailed above, and divided into five aliquots of equal volume. Aliquots
were incubated for 1 h on ice, with one of each of the five following solu-
tions to give the final detergent or NaCl concentrations as indicated: HES
alone, pH 7.4; 1% Triton X-100 (T
 
x
 
-100) in HES, pH 7.4; 60 mM 
 
b
 
-octylglu-
coside in HES, pH 7.4; 1 M NaCl in HES, pH 7.4; and 0.5 M NaCl in HES,
pH 7.4. The insoluble component of the HSP, resulting from each treat-
ment, was pelleted by centrifugation at 175,000 
 
g
 
, using a TLA 100.3 rotor
(Beckman Instruments Inc.) at 4
 
8
 
C for 1 h 15 min. The resultant pellets
were solubilized with Laemmli sample buffer and stored at 
 
2
 
20
 
8
 
C over-
night before Western blotting analysis.
Detergent-treated HSP was also prepared for electron microscopy
analysis, using a slightly modified procedure. The 30,000 
 
g
 
 supernatant
was obtained from untreated or insulin-stimulated adipocytes using the
subcellular fractionation method, as described above. Aliquots of super-
natant were mixed with an equal volume of fractionation buffer or frac-
tionation buffer containing 2% T
 
x
 
-100 and incubated for 1 h on ice. The
insoluble components were collected by centrifugation, as noted above.
Immunoblotting showed that the relevant proteins were present in the de-
tergent insoluble components of the HSP, regardless of the method used
(data not shown).
 
Sucrose Gradient Fractionation
 
In both flotation and velocity sedimentation analysis, gradients or sucrose
layers were prepared using chilled stock sucrose solutions in buffer (20 mM
Hepes, pH 7.4, 1 mM EDTA) containing phosphatase and protease inhib-
itors, as above. All sucrose concentrations are expressed as a percentage
(wt/vol). For flotation analysis, HSP prepared from untreated or insulin-
treated cells, was resuspended in 200 
 
m
 
l of HES. An aliquot of resus-
pended membranes (165 
 
m
 
l) was mixed with 835 
 
m
 
l of 70% sucrose solu-
tion to give a final concentration of 60% sucrose. This was then successively
overlaid with 1 ml of 50% sucrose, 1 ml of 30% sucrose, 1 ml of 10% su-
crose, and 400 
 
m
 
l of 5% sucrose to give a final volume of 4.4 ml. Gradients
were centrifuged (90,000 
 
g
 
 for 18 h) at 4
 
8
 
C using an SW60 rotor (Beckman
Instruments Inc.). Gradient fractions (400 
 
m
 
l) were collected by piercing
the bottom of each tube with a 27-in gauge needle. The pellet was resus-
pended in either 400 
 
m
 
l of HES or lysis buffer, as appropriate. Aliquots of
each fraction were then subjected to immunoblotting (25 
 
m
 
l) or immuno-
precipitation and PI 3-kinase assay (100 
 
m
 
l).
Velocity sedimentation analysis of the HSP fraction was performed in
continuous (5–30%) sucrose gradients (4.2 ml). The HSP fraction was pre-
pared from untreated or insulin-treated cells, and resuspended in 5% su-
crose in 20 mM Hepes, 1 mM EDTA, and layered on top of the gradient.
Gradients were centrifuged (90,000 
 
g
 
 for 90 min) at 4
 
8
 
C using an SW60 ro-
tor (Beckman Instruments Inc.). Fractions from each gradient were col-
lected as noted above, and aliquots (25 
 
m
 
l) subjected to immunoblotting.
For electron microscopy, fractions of interest were combined and diluted
in buffer, supplemented with protease and phosphatase inhibitors, to give
a final concentration of 250 mM (isotonic) sucrose. Each sample was then
subjected to centrifugation at 175,000 
 
g
 
 using a TLA 100.3 rotor (Beck-
man Instruments Inc.) at 4
 
8
 
C for 1 h 15 min. Pellets obtained from this
centrifugation were prepared for electron microscopy.
 
Electron Microscopy
 
The HSP fraction, the detergent insoluble components of the HSP, or sed-
imentable material from velocity gradient fractions of the HSP, were fixed
in 2% paraformaldehyde in PBS. Paraformaldehyde-fixed material was
randomly adsorbed to formvar-coated copper grids lightly coated with
carbon. Dry grids were incubated on 10 
 
m
 
l drops of HSP suspensions for
10 min. All grids were then washed for 7 
 
3
 
 2 min with ultra-pure water
and stained with 0.4% uranylacetate in 0.015 M oxalic acid, pH 7–8/1.8%,
methylcellulose for 5 min. Grids were dried and viewed using a Jeol 1010
transmission electron microscope.
 
Results
 
Effects of Insulin versus PDGF on Glucose Transport 
and PI 3-Kinase in 3T3-L1 Adipocytes
 
In agreement with previous studies (Wiese et al., 1995), in-
sulin stimulated glucose transport by 8- to 10-fold in 3T3-L1
adipocytes, whereas in response to PDGF, the increase
was 
 
,
 
2-fold (data not shown). To determine if this was
due to a differential effect of these growth factors on
GLUT4 translocation, adipocytes were incubated with in-
sulin or PDGF or without any additions, and cell surface
levels of GLUT4 examined. Consistent with the transport
data, insulin caused a substantial increase in cell surface
GLUT4, whereas, with PDGF, there was no significant ef-
fect (Fig. 1). In contrast, PI 3-kinase activity measured in
anti-phosphotyrosine (anti-pY) immunocomplexes was in-
creased by 8- and 10-fold of insulin and PDGF, respec-
tively (Fig. 2). The increases in PI 3-kinase activity corre-
lated with an increase in the binding of the p85 subunit of
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PI 3-kinase to tyrosyl-phosphorylated proteins, in re-
sponse to insulin or PDGF (Fig. 2). These data are in
agreement with previous observations (Wiese et al., 1995).
 
Differential Localization of PI 3-kinase in Response to 
Insulin versus PDGF
 
To study the effects of insulin versus PDGF on the intra-
cellular location of PI 3-kinase, a series of subcellular frac-
tionation studies, using 3T3-L1 adipocytes, was performed.
Adipocytes provide a useful model system for these stud-
ies, because a relatively simple fractionation procedure
has been established using differential centrifugation that
enables the isolation of fractions enriched in markers spe-
cific for PM; mitochondria/nuclei (M/N); endosomes and
endoplasmic reticulum (HDM); and intracellular mem-
branes comprising recycling endosomes, the Golgi appara-
tus, and intracellular GLUT4 storage vesicles (HSP; Simp-
son et al., 1983; James and Pilch, 1988; Piper et al., 1991;
Martin et al., 1996). The supernatant contains all elements
that do not sediment at 175,000 
 
g
 
 and is designated the
CYT. In most studies, the M/N fraction was excluded from
analysis because preliminary experiments showed that the
relevant signaling molecules were not present in this frac-
tion at significant levels.
PI 3-kinase activity was measured in anti-pY immuno-
complexes obtained from subcellular fractions of cells that
had been incubated with either insulin or PDGF (Fig. 3 
 
A
 
).
In the basal state, phosphotyrosine immunoprecipitable PI
3-kinase activity was predominantly located in the cytosol.
In response to insulin, the largest increase in PI 3-kinase
activity was detected in the HSP (9–11-fold compared to
basal, 
 
n
 
 
 
5
 
 3), and this fraction contained the largest pro-
portion of total cellular PI 3-kinase activity (53%; Fig. 3 
 
C
 
).
Insulin also caused a small but significant increase in PI
3-kinase activity in CYT, HDM, and PM fractions. In re-
sponse to PDGF, the distribution of PI 3-kinase was signif-
icantly different to that observed with insulin. The pre-
dominant PDGF-stimulated PI 3-kinase activity was found
in the PM (
 
.
 
40-fold compared to basal, 
 
n
 
 
 
5
 
 3) This frac-
tion also contained the majority (56%), of the total cellular
PI 3-kinase activity detected in response to PDGF. PDGF
also induced a significant increase in the HDM but had no
significant effect on PI 3-kinase activity in either cytosol or
HSP. These changes in general, paralleled the distribution
of anti-phosphotyrosine immunoprecipitable p85 (Fig. 3 
 
B
 
).
Given that the above measurements were performed on
anti-pY immunoprecipitates, we could not be certain that
these measurements truly reflected the distribution of PI
3-kinase within adipocytes. To address this, the distribu-
tion of the p85 subunit of PI 3-kinase was analyzed by
immunoblotting with an antibody raised against p85 (anti-
p85 
 
PAN
 
). The predominant band that was consistently la-
beled with this antibody in adipocytes had an average mo-
bility in SDS-PAGE of 85 kD (Fig. 4 
 
A
 
). However, other
bands of average mobility corresponding to 
 
z
 
100, 45, and
55 kD were routinely observed. The latter two bands likely
correspond to previously reported isoforms or splice vari-
ants of this enzyme that have been shown to cross-react
with the p85 antibody used in these studies (Inukai et al.,
1997). In the absence of hormone, the majority of immu-
noreactive p85 was found in the cytosol and HSP. With in-
sulin there was a two- to threefold increase in the immu-
noreactive p85 in the HSP fraction, commensurate with a
decrease in the cytosol and relatively little change in the
PM. In response to PDGF, there was a fivefold increase in
immunoreactive p85 in the PM, and no change in either
the HSP fraction or cytosol. The differential distribution
of immunoreactive p85 in different fractions of cells
treated with insulin versus PDGF is similar to that ob-
served in anti-pY immunocomplexes (Fig. 3 
 
B
 
). We did
not observe any significant change in the distribution of ei-
Figure 1. Effect of insulin
and PDGF on GLUT4 trans-
location in adipocytes. 3T3-L1
adipocytes cultured on cov-
erslips were brought to basal
conditions and incubated
with insulin (1 mM), or PDGF
(100 ng/ml), or no additions
(Control) for 15 min at 378C.
Cells were washed and soni-
cated to yield plasma mem-
brane fragments (PM lawns).
PM lawns were immuno-
labeled with anti-GLUT4 an-
tibody and visualized using
immunofluorescence micros-
copy. The results shown are
representative of three inde-
pendent experiments.
Figure 2. Effect of insulin
and PDGF on PI 3-kinase
activity. Whole cell lysates
from 3T3-L1 adipocytes incu-
bated with insulin (I; 1 mM)
or PDGF (P; 100 ng/ml) or
no additions (C), were sub-
jected to immunoprecipita-
tion (IP) using anti-phospho-
tyrosine antibodies (anti-pY).
Immunoprecipitates were
then subjected to either SDS-
PAGE and immunoblotting
with anti-p85PAN polyclonal
antibodies (top panel), or
analysis of PI 3-kinase activ-
ity using phosphatidylinositol
as substrate (bottom panel). The radio-labeled product, phos-
phatidylinositol 39-phosphate (PIP) was separated from unincor-
porated radiolabel (Origin) using thin layer chromatography.
Similar results were obtained in four independent experiments.
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ther the p45 or p55 immunoreactive species, suggesting
that these proteins do not respond to these growth factors.
The p55 band was enriched in the PM, whereas p45 was
enriched in the cytosol (Fig. 4 A).
The profile and subcellular distribution of tyrosine
phosphorylated proteins observed in response to insulin,
was distinctly different from that observed in response to
PDGF (Fig. 4 B). Tyrosyl-phosphorylated IRS-1 (180 kD)
was enriched in the HSP, in agreement with previous stud-
ies (Kelly and Ruderman, 1993; Heller-Harrison et al.,
1995). Several other insulin-regulated tyrosyl phosphopro-
teins in the molecular mass range 50–150 kD were also de-
tected in the HSP. The 95-kD species presumably corre-
sponds to the IR b-subunit. In agreement with previous
studies, this protein is highly enriched in the PM (Ku-
blaoui et al., 1995). The identity of the other insulin-regu-
lated phosphotyrosine proteins in the HSP is not known.
Insulin also stimulated tyrosine phosphorylation of pro-
teins of molecular mass 60 and 53 kD in the PM, that may
correspond to p60 (IRS-3; Lavan et al., 1997) and another
recently identified insulin receptor-tyrosine kinase sub-
strate, p53/p58 (Yeh et al., 1996), respectively. None of
these insulin-stimulated phosphotyrosine proteins were
observed in PDGF-treated cells (Fig. 4 B). The major
phosphotyrosine protein (195 kD) observed in PDGF-
treated cells was enriched in the PM and HDM and has an
identical electrophoretic mobility to the immunoreactive
murine PDGF receptor (data not shown).
Subcellular Distribution of IRS-1, Grb2, mSos, and Shc
As described above, PI 3-kinase and tyrosyl-phosphory-
lated IRS-1 are enriched in the HSP fraction isolated from
adipocytes, in agreement with previous studies (Kelly and
Ruderman, 1993; Heller-Harrison et al., 1995; Kublaoui et al.,
1995). As shown in Fig. 5, immunoreactive IRS-1 is also
enriched in this fraction. It is noteworthy that the IRS-1
antibody labels two proteins in the HSP of average mobil-
ity 165 and 120 kD. The upper of these two bands has a
relative molecular mass which corresponds to IRS-1 and
undergoes an apparent shift in molecular mass from 165 to
180 kD in response to insulin. It has previously been docu-
mented that IRS-1 undergoes a gel shift subsequent to
phosphorylation (Sun et al., 1992). The lower band likely
represents an unrelated protein that cross-reacts with the
antibody, as opposed to IRS-1 degradation, because we
failed to observe any evidence for tyrosine phosphoryla-
tion of a protein in this region of the gel (Fig. 4 B). In some
experiments, insulin resulted in a redistribution of IRS-1
from the HSP fraction to cytosol, consistent with previous
studies (Heller-Harrison et al., 1995). Presumably, the in-
sulin-induced redistribution of IRS-1 to the cytosol accounts
for the phosphotyrosine immunoprecipitable PI 3-kinase
activity detected in the cytosolic fraction from insulin-
treated cells, as shown above (Fig. 3, A and C). We did not
observe any significant change in the subcellular distribu-
tion of IRS-1 in response to PDGF treatment (data not
shown).
Insulin is known to activate numerous signaling mole-
cules in adipocytes. These include, Grb2, another SH2 do-
main containing protein, that reportedly binds to IRS-1 in
response to insulin (Sun et al., 1993) ; mSOS, a Grb2-bind-
ing protein (Baltensperger et al., 1993) that acts as a GTP
Figure 3. Effect of insulin
and PDGF on the subcellular
distribution of PI 3-kinase
activity. Adipocytes were
brought to basal conditions
and incubated with insulin
(I) or PDGF (P) or no addi-
tions (C). Cells were then ho-
mogenized and subjected to
differential centrifugation to
obtain fractions enriched in
plasma membrane (PM), en-
doplasmic reticulum and en-
dosomal markers (HDM),
cytosol (CYT), and a high
speed pellet fraction (HSP).
Aliquots of each fraction
(PM 25 mg; HSP, 100 mg;
HDM, 75 mg; CYT 200 mg)
representing on average 3/5,
2/5, 3/5, and 1/20 of these
fractions in whole cells, re-
spectively, were subjected
to immunoprecipitation us-
ing anti-phosphotyrosine an-
tibodies (anti-pY). Immuno-
precipitates were then used
for measurement of (A) PI
3-kinase activity, or (B) im-
munoreactive p85 using a
polyclonal anti-p85PAN anti-
body. Quantitation of the
distribution of PI 3-kinase ac-
tivity among subcellular fractions is shown in (C). Total PI 3-kinase
activity in each fraction from insulin (j), versus PDGF (h),
treated cells was calculated and expressed as percent of total after
subtracting basal values. The mean values (6 SEM) from three
independent experiments are shown. PIP, phosphatidylinositol
39-phosphate.
Figure 4. Effects of insulin
versus PDGF on subcellular
distribution of PI 3-kinase
and tyrosyl-phosphorylated
proteins in 3T3-L1 adipo-
cytes. Adipocytes were
brought to basal and incu-
bated with insulin (I), or
PDGF (P), or no additions
(C). Cells were washed, ho-
mogenized and subcellular
fractions prepared. Aliquots
of each fraction (25 mg of
protein) were analyzed by
SDS-PAGE and immunob-
lotted with antibodies spe-
cific for (A) the p85 subunit
of PI 3-kinase (anti-p85PAN)
or (B) phosphotyrosine (anti-
pY). There was no significant
change in the distribution of
p85 in the HDM with either
insulin or PDGF (not shown). Tyrosyl phosphorylation could not
be detected in the cytosol using this procedure (not shown). Re-
sults are representative of two experiments.
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exchange factor for p21 Ras; and Shc, another insulin-reg-
ulated docking protein (Skolnik et al., 1993). We next ex-
amined the distribution of these proteins in adipocytes to
determine if the localization of IRS-1 and PI 3-kinase to
the HSP fraction is specific or, alternatively, reflects a gen-
eral depot for signaling proteins (Fig. 5). In support of the
former, none of these proteins, with the exception of one
of the Shc isoforms, was enriched in the HSP fraction.
Grb2 was found in all subcellular fractions in 3T3-L1 adi-
pocytes, but was particularly enriched in the PM. In re-
sponse to insulin, there was a significant increase in the
level of Grb2 in the PM and HSP fractions, perhaps due to
its interaction with tyrosine-phosphorylated p60 (IRS-3)
and IRS-1, which are enriched in each of these fractions,
respectively (Fig. 4 B). mSOS was highly enriched in the
cytosol and did not undergo a change in subcellular distri-
bution in response to insulin stimulation. Hence, unless
mSos dissociated from Grb2 during the isolation of these
fractions, it would appear that Grb2 must bind to addi-
tional proteins in adipocytes other than mSOS, and thus
potentially recruits unique signaling proteins to either the
PM or HSP fractions.
The subcellular distribution of Shc was of particular in-
terest because this molecule encodes a similar function to
IRS-1, acting as a docking protein for downstream signal-
ing proteins (Skolnik et al., 1993). Furthermore, three dif-
ferent Shc isoforms have been reported, the individual
functions of which remain to be elucidated (Pelicci et al.,
1992). All three isoforms were detected in 3T3-L1 adipo-
cytes (Fig. 5) and, intriguingly, the subcellular distribution
of each was completely different. The 66-kD isoform was
enriched in the HDM with lower amounts also found in
the PM. The 46-kD isoform was highly enriched in the PM
(Fig. 5) and M/N (data not shown) while the 52-kD iso-
form was more widely distributed, with the majority lo-
cated in the cytosol and the HSP. Insulin did not signifi-
cantly affect the subcellular distribution of any Shc
isoform. These data clearly show that signaling proteins
have widely varying subcellular distributions in adipocytes
and this may have important implications for the specific-
ity of their biological actions. Moreover, the distribution
of Grb2, mSos, and Shc did not parallel that of IRS-1. This
implies that IRS-1 must be maintained at this location by a
specific association with another protein or membrane.
Effects of Detergents and High Ionic Strength on IRS-1 
and PI 3-kinase Solubility
To further define the nature of the interaction of IRS-1
and PI 3-kinase with the HSP, we examined the effects of
high ionic strength and different detergents on the solubil-
ity of these proteins (Fig. 6). Immunoreactive IRS-1, ty-
rosyl-phosphorylated IRS-1, and PI 3-kinase remained
largely insoluble in the presence of the two nonionic deter-
gents, Tx-100 and b-octylglucoside (b-OG). Under exactly
the same conditions, the polytopic membrane protein,
GLUT4, was completely solubilized. In contrast, denatur-
ing detergents such as SDS, completely solubilized both
IRS-1 and PI 3-kinase (data not shown). It has been sug-
gested that specialized vesicular compartments including
clathrin-coated vesicles and caveolae remain insoluble in
certain detergents (Pearse, 1982; Kurchalia et al., 1992). In
this regard, it was of interest that the g-adaptin subunit of
clathrin-coated vesicles was also largely insoluble in Tx-100
and b-OG (Fig. 6). However, as shown in Fig. 7, a large
proportion of the g-adaptin in this fraction is not associ-
ated with membranes and so this presumably represents
preassembled adaptor complexes that can be sedimented.
It is highly unlikely that the detergent insoluble fraction,
containing IRS-1 and PI 3-kinase, represents caveolae be-
cause these organelles are generally quite soluble in the
nonionic detergent b-OG (Brown and Rose, 1992). More-
over, we have shown that caveolin, a major constituent of
caveolae, is not enriched in our HSP fraction, but remains
Figure 5. Subcellular distri-
bution of IRS-1, Grb2, mSos,
and Shc isoforms in adipo-
cytes under basal and insulin-
treated conditions. Adipo-
cytes were brought to basal
conditions and incubated in
the absence (2) or pres-
ence(1) of insulin (1 mM) for
15 min at 378C. Cells were
washed, homogenized and
subcellular fractions pre-
pared. Aliquots of each frac-
tion (25 mg of protein), the
plasma membrane (PM), cy-
tosol (CYT), high speed pel-
let (HSP), and high density
microsomal (HDM) fractions,
were analyzed by SDS-PAGE and immunoblotted with antibod-
ies specific for IRS-1, Grb2, mSos, or Shc, respectively. The re-
sults shown are representative of two independent experiments.
Figure 6. Effects of nonionic
detergents and high ionic
strength on the high speed
pellet (HSP) fraction from
adipocytes. Adipocytes were
brought to basal conditions
and incubated in the absence
or presence of insulin (1 mM),
and then subjected to differ-
ential centrifugation to gen-
erate the HSP fraction. The
HSP was incubated in buffer
(Hepes, pH 7.4, 1 mM EDTA,
250 mM sucrose) or the same
buffer containing 1% Triton
X-100 (Tx-100), 60 mM b-octyl-
glucoside (b-OG), 1.0 M NaCl,
or 0.5 M NaCl, at 48C for 1 h,
and then subjected to centrif-
ugation at 175,000 g. The re-
sultant pellets were analysed
by SDS-PAGE and immu-
noblotted with antibodies
specific for IRS-1, phospho-
tyrosine (anti-pY), PI 3-kinase
(anti-p85PAN), GLUT4, and
g-adaptin, respectively. The
results are representative of
three independent experi-
ments.
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attached to the plasma membrane. In addition, the minor
pool of caveolin found in the HSP, is substantially solubi-
lized by 1% Tx-100 (Hill, M., S. Clark, D. James, manu-
script submitted for publication). In the presence of high
ionic strength, both IRS-1 and PI 3-kinase were com-
pletely solubilized, suggesting that these proteins are re-
tained in the HSP fraction via ionic interactions (Fig. 6).
PI 3-kinase–IRS-1 Complexes Are Not Associated with 
Membranes within the Adipocyte HSP
Specialized lipid micro-domains have been described,
based on their resistance to solubilization with various
nonionic detergents (Simons and Ikonen, 1997). These do-
mains may be enriched in certain membrane lipids, such as
glycolipids that confer detergent insolubility. One of the
features that defines these types of structures, aside from
detergent insolubility, is their buoyancy in hypertonic su-
crose, due to the presence of lipid (Brown and Rose,
1992). In contrast, protein complexes and cytoskeletal ele-
ments do not exhibit this property (Fra et al., 1994). To de-
termine if IRS-1 and PI 3-kinase are localized to a special-
ized lipid microdomain, the HSP fraction was loaded at
the bottom of a discontinuous sucrose gradient and centri-
fuged for 18 h (Fig. 7). The HSP was resolved into two sep-
arate peaks of protein using this approach. The major
peak (peak 1), which contained z65% of HSP protein, re-
mained at the bottom of the gradient in the 60% sucrose
fraction. The second peak (peak 2) contained z33% of
HSP protein and was found in the middle of the gradient
corresponding to the 30/50% sucrose interface. The distri-
bution and recovery of protein in peaks 1 and 2 were not
significantly different when HSP fractions were harvested
from basal versus insulin-treated cells (Fig. 7, A and B).
IRS-1 and PI 3 kinase were found exclusively in peak 1
both in basal and insulin-treated cells. Notably, we ob-
served in these studies an insulin-dependent loss of IRS-1
from the HSP fraction that was presumably due to the re-
distribution of this protein to the cytosol (Figs. 5 and 6).
Consistent with the studies described above (Fig. 4), there
was a significant increase in IRS-1 tyrosine phosphorylation
with insulin and an increase in PI 3-kinase associated with
the HSP. However, these effects of insulin were only ob-
served in peak 1, suggesting that neither IRS-1 nor PI 3-kinase
Figure 7. Flotation analysis of the high speed
pellet (HSP) fraction prepared from adipo-
cytes. The HSP subcellular fraction from un-
treated (A) or insulin-treated (B and C) adipo-
cytes was prepared and resuspended in buffer
(Hepes, pH 7.4, 1 mM EDTA) containing 60%
sucrose in a final volume of 1 ml. This fraction
was successively overlaid with buffer (1 ml)
containing 50, 30, and 10% sucrose and 400 ml
of buffer containing 5% sucrose. Sucrose gradi-
ents were then centrifuged at 90,000 g for 18 h.
Fractions (400 ml) were collected from the bot-
tom (1–11) of each gradient by gravity and the
pellet (P) was solubilized in 400 ml of buffer.
Aliquots of each fraction were used for mea-
surement of total protein content or immuno-
blotted with antibodies specific for IRS-1, phos-
photyrosine (anti-pY) PI 3-kinase (anti-p85PAN)
or GLUT4. (C) Aliquots of each fraction (100 ml)
were immunoprecipitated with anti-phosphoty-
rosine antibodies and assayed for PI 3-kinase
activity. Radio-labeled product, PIP, present in
each immunoprecipitate was resolved by TLC
(inset), excised, and quantitated by scintillation
counting. The result shown depicts the percentage of PI 3-kinase activity immunoprecipitated from the pellet (P) and fractions (1–7),
relative to total activity present in the entire gradient. Immunoprecipitates of fractions 8–11 contained ,1% of total PI 3-kinase activity
present in the entire gradient, and is not shown. Results are representative of two independent experiments.
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are associated with lipid-containing domains. As a control
for the flotation analysis we also immunoblotted each frac-
tion with an antibody specific for GLUT4. As expected,
GLUT4-containing membranes quantitatively floated to a
position in the gradient, corresponding to peak 2, propor-
tional to the buoyant density of these membranes. In addi-
tion, it was noted that the amount of GLUT4 recovered in
peak 2 from insulin-treated cells was significantly less than
that from basal cells consistent with its movement from
the HSP to the plasma membrane (see Fig. 1). This indi-
cates that peak 2 contains the insulin-regulatable GLUT4
storage vesicles. Fractions were also immunoblotted with
an antibody specific for g-adaptin. Although the majority
of this protein remained in peak 1, presumably represent-
ing preformed adaptor complexes, a significant amount
was also found in peak 2. Hence, this indicates that the
HSP contains coated vesicles and these remain intact dur-
ing this fractionation procedure. A tyrosine-phosphory-
lated protein of Mr 95 kD, presumably corresponding to
the b subunit of the IR, was also detected in peak 2 isolated
from insulin-treated cells (Fig. 7 B).
These studies suggest that we have been able to segre-
gate the HSP into two distinct fractions corresponding to
peaks 1 and 2. Peak 1 contains the majority of protein as
well as IRS-1 and PI 3-kinase, whereas peak 2 contains
membranes and vesicles as determined by the presence of
GLUT4, the IR and g-adaptin. To rule out the possibility
that a small amount of IRS-1 or PI 3-kinase, that is unde-
tectable by immunoblotting, may remain associated with
membranes in peak 2, we also measured PI 3-kinase activ-
ity in phosphotyrosine immunoprecipitates of each frac-
tion from flotation gradients. This assay is much more sen-
sitive than blotting and should provide a more quantitative
measure of the distribution of this protein. Consistent with
the distribution of immunoreactive p85 (Fig. 7 B), the ma-
jority (95%) of insulin-stimulated PI 3-kinase activity was
recovered in peak 1 and the activity present in peak 2 was
not significantly different from background (Fig. 7 C).
Hence, these data indicate that PI 3-kinase does not asso-
ciate with membranes within the HSP.
One possibility is that IRS-1 and PI 3-kinase complexes
may dissociate from membranes during the flotation anal-
ysis and, thus, remain at the bottom of the gradient as free
protein. If this were the case, it would be expected that
these proteins would now behave as cytosolic proteins,
and not sediment under the conditions that were originally
used to generate this fraction. To address this possibility,
the 60% sucrose fractions (F1 and F2) that comprised
peak 1 from flotation gradients were diluted with buffer to
achieve an isotonic sucrose concentration and resedi-
mented. As shown in Fig. 8, a large proportion of both
IRS-1 and PI 3-kinase were recovered in the pellets (P1
and P2) from both of these fractions. Thus, these data sug-
gest that IRS-1 and PI 3-kinase are not associated with
membranes in the HSP fraction and that their presence in
this fraction must reflect an interaction with other proteins
that render them detergent insoluble.
Velocity Sedimentation Analysis of the HSP
To further characterize the nature of the IRS-1–PI 3-kinase
complex in adipocytes, we next subjected the HSP to ve-
locity sedimentation analysis. This procedure separates
particles on the basis of size rather than density. Under
these conditions the majority of protein (68%) in the HSP
remained at the top of the gradient (fractions 8–10) and,
consistent with the flotation analysis, this peak contained
the majority of IRS-1, tyrosyl-phosphorylated IRS-1 and
PI 3-kinase (Fig. 9, A and B). Insulin stimulation did not
substantially alter the velocity sedimentation profile of to-
tal protein nor IRS-1 (Fig. 9 B). However, we again ob-
served an insulin-dependent loss of IRS-1 from the HSP
which was presumably due to the re-distribution of this
protein to the cytosol (Fig. 7, A and B). The insulin-stimu-
lated increase in PI 3-kinase in the HSP cosedimented
with the pool of tyrosyl-phosphorylated IRS-1. The major-
ity (.80%) of immunoreactive GLUT4 in the HSP sedi-
mented in zones (fractions 2–7) of the gradient that were
devoid of IRS-1 and PI 3-kinase. There was a slight over-
lap between the GLUT4 peak and the IRS-1–PI 3-kinase
peak. However, in view of the flotation studies described
above, this almost certainly corresponds to the limited res-
olution of this technique and does not reflect colocalization
of these proteins. Hence, using this technique, it would ap-
pear that IRS-1 and PI 3-kinase that remain in the upper
portion of the velocity gradient, are not associated with
membranes that sediment deeper into the gradient.
IRS-1 and PI 3-Kinase Have Similar Properties in Other 
Cell Types
IRS-1 is expressed at high levels in insulin-sensitive cell
types, including adipocytes and myocytes (White, 1994).
To determine if the association of IRS-1 and PI 3-kinase
with insoluble proteinaceous particles is only a feature of
these cell types, we performed similar experiments, to
those described above, in CHO cells. CHO cells do not
normally express significant levels of either IR or IRS-1
and this, in part, accounts for their lack of insulin sensitiv-
ity. Hence, we used CHO cells that have been stably trans-
fected with the IR and IRS-1 cDNAs (Sun et al., 1992).
Consistent with previous studies (Heller-Harrison et al.,
Figure 8. Resedimentation
of IRS-1 and PI 3-kinase sub-
sequent to sucrose gradient
centrifugation. The HSP
fraction from insulin-treated
cells was subjected to flota-
tion analysis as described in
Fig. 7. Fractions 1 (F1) and 2
(F2) comprising Peak 1 from
this gradient were made iso-
tonic with buffer (20 mM
Hepes, pH 7.4, 1 mM
EDTA), and centrifuged at
175,000 g for 1 h 15 min. The
corresponding pellets (P1
and P2), together with an
equivalent amount of the
starting fractions (F1 and
F2), were subjected to SDS-PAGE and immunoblotted with spe-
cific antibodies for IRS-1 and PI 3-kinase (anti-p85PAN). Identical
results were also obtained using HSP isolated from basal cells
and are not shown.
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1995), we observed that a significant fraction of both IRS-1
and PI 3-kinase in these cells was found in an HSP fraction
(see Fig. 11). The CHO/IR/IRS-1 cell HSP was next sub-
jected to velocity gradient analysis and fractions were im-
munoblotted as described above (Fig. 10, A and B). The
distribution of IRS-1, tyrosyl-phosphorylated IRS-1, and
p85 in CHO cells was almost identical to that observed in
adipocytes (Fig. 9). Moreover, insulin induced a significant
increase in IRS-1 tyrosine phosphorylation and recruit-
ment of PI 3-kinase in CHO/IR/IRS-1 cells that was com-
mensurate with that observed in adipocytes (Fig. 10, B).
Hence, these data suggest that the nonmembrane associ-
ated, insolubility of IRS-1 and PI 3-kinase that presumably
results from the association of these proteins with a large
protein complex, is a feature of many cells, and can be re-
capitulated using recombinant IRS-1 expressed in a cell
type that normally expresses low levels of this protein.
Maintenance of the IRS-1–PI 3-Kinase Complex in 
Permeabilized Cells
The cytosolic or nonsedimentable pool of both IRS-1 and
PI 3-kinase in CHO/IR/IRS-1 cells is significantly larger
than is observed in adipocytes and can be readily detected
by immunoblotting. Hence, this provided a useful system
with which to experimentally define the existence of the two
pools, cytosolic versus insoluble, of IRS-1 and PI 3-kinase
in the intact cell. If the insoluble sedimentable pool of
IRS-1 and PI 3-kinase represents a large preformed pro-
tein complex within the cell, then it should be retained af-
ter permeabilization. Whereas, provided the pores are suf-
ficiently large, the cytosolic component of these proteins
should be released from the cell under the same experi-
mental conditions. The bacterial endotoxin, SLO, provides
a useful reagent to achieve this purpose because it intro-
duces large pores in the plasma membrane, leaving the re-
mainder of the cell completely intact. As shown in Fig. 11,
the majority of IRS-1 and immunoreactive p85 found in
the cytosolic fraction was released from cells subsequent
to permeabilization with SLO. In contrast, a substantial
proportion of immunoreactive p85 and IRS-1, associated
with the HSP fraction, was retained in permeabilized cells.
We have also shown that a significant proportion of IRS-1
and PI 3-kinase is retained in SLO-permeabilized 3T3-L1
adipocytes (data not shown). However, because we do not
observe a significant amount of IRS-1 in the cytosol of
these cells, we have not been able to examine the release
of this pool subsequent to permeabilization and, as is
shown in the case of the CHO/IR/IRS-1 cells, this provides
a very useful control. Notwithstanding, these studies col-
lectively demonstrate that the insoluble fraction of IRS-1
and PI 3-kinase, which we have isolated biochemically in
these studies, can also be experimentally defined as a large
complex that is retained in cells, even under conditions
where the cytosolic component of these same proteins is
freely permeable.
Electron Microscopy Analysis of the HSP
We have previously shown that the HSP fraction isolated
from adipocytes contains numerous vesicles ranging in di-
ameter from 70–200 nm (James and Pilch, 1988; Martin et al.,
Figure 9. Sedimentation velocity analysis of
the HSP from 3T3-L1 adipocytes. The HSP
fraction obtained from basal (A), or insulin-
treated adipocytes (B), was resuspended in
buffer (20 mM Hepes, pH 7.4, 1 mM EDTA,
200 ml) containing 5% sucrose, and overlaid
on to a 5–30% continuous sucrose gradient.
Gradients were centrifuged at 90,000 g for 90
min, and fractions (400 ml) collected from the
bottom (1–11) of each gradient by gravity. Al-
iquots of each fraction were assayed for pro-
tein content, or resolved by SDS-PAGE (30 ml)
and subjected to immunoblotting with anti-
bodies specific for IRS-1, phosphotyrosine
(anti-pY), PI 3-kinase (anti-p85PAN), and GLUT4.
The results are representative of two inde-
pendent experiments.
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1996). Immunogold labeling studies have revealed that
these vesicles are enriched in a variety of membrane and
coat-associated proteins including GLUT4, VAMP2, and
the mannose-6-phosphate receptor, (Martin et al., 1996).
As shown in Fig. 12, electron microscopy of the IRS-1–PI
3-kinase peak and the GLUT4 peak, obtained by velocity
centrifugation of the 3T3-L1 adipocyte HSP (Fig. 9), re-
vealed that the latter, but not the former, was highly en-
riched in vesicles (Fig. 12, A and B). Intriguingly, long, fil-
amentous structures with an estimated diameter of 5–15
nm, that resemble cytoskeletal elements (Kries and Vale,
1993), were preferentially retained in the gradient peak
enriched in IRS-1 and PI 3-kinase. These structures were
decorated with electron opaque particles with an esti-
mated diameter of 10–50 nm, that, presumably, corre-
spond to large protein complexes (Fig. 12 A). Similar fila-
mentous structures were present in the Tx-100–insoluble
component of the HSP, although in this instance, they ap-
peared to be less labyrinthine and were decorated with
large electron dense sacs (Fig. 12 C). These filamentous
structures are present in the HSP, isolated from a variety
of cell types, including both rat adipocytes and 3T3-L1 ad-
ipocytes, but appear more elongated in the HSP isolated
from rat adipocytes (data not shown). Immunolocalization
of either IRS-1 or PI 3-kinase in these fractions have been
unsuccessful and so it remains to be determined if these
proteins are directly associated with these cytoskeletal ele-
ments.
Discussion
PI 3-kinase plays a central role in numerous biological
processes, including thrombin activation of platelets, apop-
tosis, growth factor–induced cell proliferation, differentia-
tion, membrane ruffling, and insulin regulation of glucose
metabolism (Toker and Cantley, 1997). Understanding
how this enzyme acts as the focal point for such a diverse
range of biological actions remains a major challenge. In
the present study, we have addressed this problem by fo-
cusing on the insulin regulation of glucose transport in adi-
pocytes. This provides a useful paradigm because consid-
erable evidence supports a role for PI 3-kinase in insulin
action and the regulation of glucose transport in adipo-
cytes is quite specific to the hormone, insulin (Robinson
et al., 1993; Vandenberghe et al., 1994; Wiese et al., 1995).
An anomalous observation, that potentially confounded
the specific role of PI 3-kinase in this process, was that
PDGF also activates PI 3-kinase in adipocytes, quantita-
tively to the same extent as insulin, yet this growth factor is
incapable of activating glucose transport or GLUT4 trans-
location to the cell surface (Wiese et al., 1995).
A major difference between insulin and PDGF signaling
is that insulin uses a putatively soluble substrate, IRS-1, as
a docking site for downstream signaling intermediates,
such as PI 3-kinase, whereas PDGF uses its receptor for
this purpose (Kazlauskas et al., 1992). Hence, we reasoned
that this difference may confer specificity at the level of in-
tracellular compartmentation, thus enabling PI 3-kinase to
access a unique array of downstream effectors in either
case. Using subcellular fractionation analysis, we verified this
notion and showed that, in response to PDGF, PI 3-kinase
was recruited to the plasma membrane, whereas, in the
case of insulin, PI 3-kinase was recruited to an intracellular
fraction, designated as HSP, that was quite distinct from
the plasma membrane. The PDGF-activated receptor is,
of course, enriched in the plasma membrane fraction,
whereas IRS-1 is enriched in the HSP, consistent with the
original hypothesis. These observations, which represented
the impetus for these studies, has since been reported by
two other groups and largely confirms the central tenet
that the cellular location of PI 3-kinase may somehow confer
biological specificity (Nave et al., 1996; Ricort et al., 1996).
Figure 10. Sedimentation velocity analysis of
the HSP from CHO/IR/IRS–1 cells. The HSP
fraction obtained from basal (A), or insulin-
treated (B), CHO cells overexpressing the in-
sulin receptor (IR) and IRS-1, was resus-
pended in buffer (20 mM Hepes, pH 7.4,
1 mM EDTA, 200 ml) containing 5% sucrose,
and overlaid on to a 5–30% continuous su-
crose gradient. Gradients were centrifuged at
90,000 g for 90 min, and fractions (400 ml) col-
lected from the bottom (1–11) of each gradi-
ent by gravity. Aliquots of each fraction were
assayed for protein content, or resolved by
SDS-PAGE (30 ml) and subjected to immu-
noblotting with antibodies specific for IRS-1,
phosphotyrosine (anti-pY), and PI 3-kinase
(anti-p85PAN).
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To further define the molecular basis for this differential
compartmentalization of PI 3-kinase, we focused our ef-
forts on characterizing the composition of the adipocyte
HSP and, in particular, in defining the nature of the inter-
action of both IRS-1 and PI 3-kinase with this fraction. Im-
portantly, IRS-1 was enriched in the HSP under basal con-
ditions. Given that the bulk of tyrosyl-phosphorylated
IRS-1 in cells treated with insulin remained associated
with the HSP, it is more than likely that IRS-1 interacts
with the insulin receptor in this fraction (Figs. 4 B and 5).
Intriguingly, although insulin recruits PI 3-kinase from the
cytosol to the HSP, presumably due to increased binding
to tyrosyl-phosphorylated IRS-1, there is a significant
component of PI 3-kinase found in the HSP in basal cells
(Fig. 4 A). This may reflect PI 3-kinase bound to tyrosyl-
phosphorylated IRS-1 because we could detect a phospho-
tyrosine protein of similar relative molecular mass in the
HSP from basal cells (Figs. 4 B and 5). Apart from this, how-
ever, there is no a priori reason to suggest that PI 3-kinase
is only located at this site by coupling with IRS-1. Indeed,
the preassembly of these proteins in a complex may facili-
tate the necessary fidelity required to ensure that these
proteins can rapidly associate in response to insulin. The
HSP also contains other signaling molecules such as the
52-kD isoform of Shc, (Fig. 5) as well as other insulin-reg-
ulated phosphoproteins of unknown identity (Fig. 4 B;
Hill, M., S. Clark, and D. James, manuscript submitted for
publication). However, Grb2, the 46 and 66 kD isoforms
of Shc (Fig. 5), MAPK (Hill, M., and D. James, unpub-
lished observations), the tyrosyl-phosphorylated insulin
receptor and two other insulin-regulated tyrosyl phos-
phoproteins of relative molecular mass p60 and p53 (Fig. 4
B) are not enriched in this fraction, suggesting that this is
not simply an aggrophore of signaling intermediates.
In addition to IRS-1 and PI 3-kinase, the HSP is also en-
riched in the intracellular GLUT4 storage compartment
(Fig. 7; James et al., 1988). Hence, this raises the provoca-
tive notion that PI 3-kinase may directly bind to these ves-
icles, thus, regulating their exocytic movement. Indeed,
evidence has been documented in favor of this model
(Heller-Harrison et al., 1996). However, intuitively, this
seems unlikely because PI 3-kinase also mediates the acti-
vation of the pp70 ribosomal protein S6-kinase, indepen-
dently of glucose transport (Fingar et al., 1993). In addi-
tion, PI 3-kinase mediates the activation of the serine
kinase, protein kinase B, (Akt/PKB), that has also been
implicated in the regulation of glucose transport in adipo-
cytes, thus, denoting an important role for PI 3-kinase as
an intermediate in this process (Kohn et al., 1996). We
have obtained several independent experimental observa-
tions in the present studies to suggest that neither IRS-1
nor PI 3-kinase are directly associated with GLUT4-con-
taining membranes, nor any membrane in the adipocyte
HSP fraction. First, IRS-1 and PI 3-kinase are insoluble in
nonionic detergents, whereas membrane proteins such as
GLUT4 are completely soluble under these conditions
(Fig. 6). Second, flotation analysis using sucrose density
gradient sedimentation of the HSP resolved this fraction
into two discrete peaks: one containing membranes, in-
cluding GLUT4 vesicles, and the other containing non-
membrane-associated proteins. IRS-1 and PI 3-kinase
were exclusively found in the latter fraction and did not
overlap with the peak of GLUT4 (Fig. 7). Third, using ve-
locity sedimentation, the majority of PI 3-kinase and IRS-1
were segregated from vesicles containing GLUT4 and
other proteins (Fig. 9). Finally, we were unable to detect
the presence of vesicular structures in gradient fractions
enriched in IRS-1 and PI 3-kinase (Fig. 12). Conversely,
these fractions were enriched in cytoskeletal elements,
which, based on their diameter (.10 nm), resembled cy-
toskeletal filaments. Thus, the present studies do not sup-
port the concept that insulin stimulates the recruitment of
PI 3-kinase to the intracellular GLUT4 compartment as
described previously (Heller-Harrison et al., 1996). In this
report, it was suggested that this association may be very
transient, occurring at early times after insulin addition.
However, we have isolated the HSP from adipocytes incu-
bated as described in the forementioned study, and sub-
jected this fraction to gradient analysis as described above
(Fig. 7), and yet find no evidence for a direct association
between these signaling proteins and GLUT4 (data not
shown). It is also unlikely that these proteins dissociated
from membranes during the course of our isolation proce-
dure because we were able to resediment both IRS-1 and
PI 3-kinase subsequent to flotation analysis (Fig. 8).
We have not clearly established, from the present stud-
ies, the molecular basis by which IRS-1 and PI 3-kinase are
targeted to what appears to be an insoluble protein matrix.
However, several observations support their interaction
with the cytoskeleton. First, the sucrose gradient fractions
which contain these proteins are highly enriched in cyto-
skeletal elements as determined by electron microscopy
(Fig. 12). Second, the cytoskeleton is reportedly insoluble
in nonionic detergents, readily sediments using ultra-cen-
trifugation, and can be disrupted by high ionic strength
(Kries and Vale, 1993). IRS-1 and PI 3-kinase exhibited
each of these properties (Figs. 4–6). Third, the cytoskele-
ton would remain intact subsequent to permeabilization of
cells with SLO, and this is consistent with the maintenance
of a pool of IRS-1 and PI 3-kinase within SLO-permeabi-
lized CHO/IR/IRS-1 cells (Fig. 11). Finally, it has been
shown that PI 3-kinase is highly enriched in cytoskeletal
fractions isolated from other cell types including platelets
(Zhang et al., 1992) and fibroblasts (Kapeller et al., 1993).
Figure 11. Retention of IRS-1
and PI 3-kinase within per-
meabilized CHO cells. CHO
cells overexpressing IR and
IRS-1 were brought to basal
conditions and then incu-
bated in the absence (2) or
presence (1) of Streptolysin-O
(SLO) to perforate the cells.
Cells were washed, homoge-
nized, and subjected to dif-
ferential centrifugation to ob-
tain the high speed pellet
(HSP) and cytosolic (CYT)
fractions. Aliquots of each
fraction (15 mg of protein)
were subjected to SDS-PAGE
and immunoblotted with an-
tibodies specific for IRS-1
and PI 3-kinase (anti-p85PAN).
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We have attempted to immunolocalize both IRS-1 and PI
3-kinase in adipocytes and CHO/IR/IRS-1 cells. However,
these analyzes have been largely confounded by the lack
of specificity of available antibodies. Whereas IRS-1 ap-
pears to be localized to the cytosol in CHO cells (Sun et al.,
1992), this may reflect staining of the rather large cytosolic
pool of IRS-1 that is evident in these cells (Fig. 11). We
have failed to observe an effect of agents known to disrupt
either microtubules or microfilaments on the distribution
of IRS-1 or PI 3-kinase in 3T3-L1 adipocytes (data not
shown). Furthermore, we do not observe any effect of
these agents on insulin action. Hence, the nature of this
putative cytoskeletal attachment remains to be determined.
If IRS-1 and PI 3-kinase are associated with the cyto-
skeleton in adipocytes, how then do they gain access to
their regulatory intermediates which, in this case, corre-
spond to the insulin receptor and the inner leaflet of a lipid
bilayer, respectively? As described earlier, a large propor-
tion of the available IRS-1 pool is rapidly phosphorylated
subsequent to insulin addition (Madoff et al., 1988) and
this occurs under conditions where internalization of the
insulin receptor is inhibited (Heller-Harrison et al., 1995).
One model that would account for these findings, is that
IRS-1 and PI 3-kinase may be tethered to elements of the
cytoskeleton that directly underlie the plasma membrane
of the cell. This structure, which is composed primarily of
actin filaments, has been documented in other cell types
and has been referred to as a membrane skeleton (Mays et
al., 1994). This membrane skeleton may serve several im-
portant functions in adipocytes. First, by preassembling
the proteins that comprise the insulin-signaling cascade
onto a cytoskeletal scaffold, this may ensure the correct
juxtaposition of different enzymes in this cascade enabling
them to interact in a very robust manner. In this regard, it
is noteworthy that both IRS-1 and PI 3-kinase are found in
the cytoskeletal fraction in both nonstimulated adipocytes
and CHO/IR/IRS-1 cells (Figs. 9 and 10). Indeed, it will be
of interest to determine if other downstream signaling pro-
teins are found at this location as well. Second, the cyto-
skeleton may provide a barrier through which recycling
vesicles have to transit en route to the cell surface. Several
studies have ascertained that receptor-mediated endocyto-
sis and the trafficking of intracellular secretory vesicles to
the cell surface, in a variety of cell types, requires an intact
cytoskeleton (Mays et al., 1994). Thus, by regulating the
integrity of this barrier, it may be possible to regulate the
recycling rate of certain membranes. In this respect, the PI
3-kinase inhibitor, wortmannin, has been shown to inhibit
the insulin-regulated exocytosis of a number of mem-
brane-associated proteins to the cell surface in adipocytes,
including the transferrin receptor and Rab4, in addition to
GLUT4 (Shepherd et al., 1995; Cormont et al., 1996). Fi-
nally, by regulating the association of integral signaling
molecules with this cytoskeletal scaffold, it may be possi-
ble to regulate hormonal responsiveness. Of note in this
regard, and consistent with recent studies (Heller-Harri-
son et al., 1995), is the insulin-dependent release of IRS-1
from the HSP (Figs. 6, 7, and 9). It appears, from these
studies, that tyrosyl-phosphorylated IRS-1 is tightly retained
within the HSP, thus providing further evidence that the
insulin-dependent release of IRS-1 from this fraction may
correspond to serine phosphorylation of IRS-1. Temporal
differences in the phosphorylation of IRS-1 on tyrosine
versus serine residues in response to insulin have been re-
ported, with serine phosphorylated IRS-1 predominating
under prolonged insulin-stimulated conditions (Sun et al.,
1992). In fact, serine phosphorylation of IRS-1 correlates
with reduced insulin signaling, as evident in cells treated
with okadaic acid (Tanti et al., 1994) or tumor necrosis fac-
tor-a (Hotamisligil et al., 1996). Hence, the release of IRS-1
from its cytoskeletal anchor, an event that may be triggered
by serine phosphorylation, may rapidly terminate the insu-
lin signal simply by preventing access of IRS-1 to the IR.
In conclusion, these studies point to an important role
for the subcellular localization of signaling intermediates
in regulating specific biological events. Our data raise the
Figure 12. Identification of bundles of filamentous networks in
HSP fraction, and the detergent insoluble component of this frac-
tion, from adipocytes. The HSP fraction from basal adipocytes was
subjected to velocity sedimentation analysis through sucrose gra-
dients as described in Fig. 9. Fractions enriched in GLUT4 (frac-
tions 5–7) or IRS-1/PI 3-kinase (fractions 8–10) were pooled and
made isotonic by diluting in buffer (20 mM Hepes, pH 7.4, 1 mM
EDTA) and subjected to high speed centrifugation. The resultant
pellet from this step was resuspended in PBS and subsequently
fixed in 2% paraformaldehyde/PBS, and subjected to electron
microscopy analysis. Electron micrographs of paraformaldehyde-
fixed samples obtained from gradient fractions enriched in (A)
IRS-1/PI 3-kinase and (B) GLUT4 are shown. In separate exper-
iments, (C) the Tx-100–insoluble component of the HSP fraction
was prepared and fixed in 2% paraformaldehyde/PBS and sub-
jected to electron microscopy analysis. Bars, 200 nm.
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intriguing possibility that IRS-1 and one of its downstream
effectors, PI 3-kinase, are localized to the cytoskeleton. It
is within this context that both of these proteins are acti-
vated by the IR, suggesting that this scaffold must directly
appose the plasma membrane. This raises the question,
which represents the major impetus for these studies, as to
why the PDGF receptor, which is also enriched in the plasma
membrane of adipocytes (Fig. 4 B) and binds PI 3-kinase
in response to PDGF stimulation (Fig. 3), is incapable of
regulating glucose transport (Fig. 1). One possibility is that
the attachment of PI 3-kinase to the cytoskeleton affords
access not only to the lipid bilayer, but also to the relevant
downstream target(s) of the 39-phosphorylated phospho-
inositide products of this enzyme, that may also be local-
ized to this site. The other possibility is that the PDGF re-
ceptor may be sequestered within a microdomain of the
plasma membrane that prevents its access to these down-
stream targets and/or to the relevant lipid substrates which
result in the generation of 39-phosphorylated phospho-
inositides. In support of the latter, it has been shown that,
despite the recruitment of a significant amount of PI 3-kinase
to the plasma membrane in PDGF-treated adipocytes
(Fig. 3), PDGF does not significantly stimulate the pro-
duction of 39 phosphorylated phospholipids (Conricode,
1995), nor does it activate downstream targets such as Akt/
PKB, with the same potency as insulin (Tanti et al., 1997).
Such sequestration mechanisms may be important in ter-
minally differentiated cells to subvert the inappropriate
activation of growth factor receptors.
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